公开(公告)号：US11202577B2

公开(公告)日：2021-12-21

申请号：US16664946

申请日：2019-10-28

申请人： Ming-Hsin Li ,  Kai-Hung Cheng ,  Shih-Wei Lo

发明人： Ming-Hsin Li ,  Kai-Hung Cheng ,  Shih-Wei Lo

IPC分类号： A61B5/0205 ,  A61B5/029 ,  A61B5/00 ,  A61B5/021 ,  A61B5/024 ,  A61B5/369

摘要： A system and method for monitoring cardiovascular and brain functions in combination with a physiological detection device, which uses a smart wearable device to detect physiological data such as heart rate and pulse pressure of a user, and transmits the physiological data to an arithmetic function. An electronic device in which a preset function and a calculation formula are built in, and the physiological data can be converted into corresponding determination parameters to monitor the possibility and risk of cardiovascular diseases and neurodegenerative diseases.

公开(公告)号：US20210121585A1

公开(公告)日：2021-04-29

申请号：US16663387

申请日：2019-10-25

申请人： MING-HSIN LI ,  Sheng-Nan Lo ,  Shih-Wei Lo ,  Shih-Ying Lee ,  Su-Jung Chen ,  Shih-Min Wang ,  Ming-Wei Chen ,  Wei-Lin Lo

发明人： MING-HSIN LI ,  Sheng-Nan Lo ,  Shih-Wei Lo ,  Shih-Ying Lee ,  Su-Jung Chen ,  Shih-Min Wang ,  Ming-Wei Chen ,  Wei-Lin Lo

IPC分类号： A61K51/08

摘要： The invention features a novel precursor provided for radioisotope labeling with ligands for specific binding of prostate-specific membrane antigen (PSMA) for prostate cancer diagnosis and treatment, and the pharmacophore of a PSMA inhibitor composed of three molecules of glutamic acid, urea and lysine is provided with three variable linkers based on pharmacological activity of the PSMA inhibitor for labeling with radioactive nucleus Ga-67, Ga-68, In-111, Lu-177, Cu-64, or Y-90 through a chelating agent for imaging analysis of human tumor models of prostate cancer and serving as a PSMA-targeted radioligand therapy for prostate cancer diseases.

公开(公告)号：US20200078478A1

公开(公告)日：2020-03-12

申请号：US16125787

申请日：2018-09-10

申请人： Ming-Hsin Li ,  Ming-Wei Chen ,  Shin-Min Wang ,  Shih-Wei Lo ,  Chun-Fang Feng ,  Cheng-Hui Chuang ,  Sheng-Nan Lo

发明人： Ming-Hsin Li ,  Ming-Wei Chen ,  Shin-Min Wang ,  Shih-Wei Lo ,  Chun-Fang Feng ,  Cheng-Hui Chuang ,  Sheng-Nan Lo

IPC分类号： A61K51/04

摘要： A PSMA targeting peptide derivative for radiotherapy, which is a structural molecule developed for diagnosis or treatment of prostate cancer, as prostate-specific membrane antigen (PSMA) is a protein present on the surface of healthy prostate cells, which is often at a high level of expression on the surface of prostate cancer cells, and the molecular composition of PSMA inhibitor is mainly composed of glutamic acid, urea and lysine, in addition to the linker of the present invention, PSMA inhibitor can be combined with a chelating agent and truncated Evans Blue, which can be labeled with radionuclides Ga-67, Ga-68, In-111, Lu-177, Cu-64 or Y-90, used for image analysis and analysis of human prostate cancer tumor pattern as a new PSMA targeting peptide receptor radionuclide therapy (PRRT), and which has a longer half-life in vivo and is featured by specific binding of PSMA for radiotherapy diagnosis or treatment.